PUBLIC CONTRACT · 2021

12100021-Aquisição medicamentos “adalimumab 40 mg/0,8ML sol inj caneta 0,8 m sc” no 2o sem 2021

Contract value: €23,280.00
Signed on: 11 October 2021
Procedure: Prior consultation (Consulta Prévia)

This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.

Record 8244229

PUBLISHED DESCRIPTION

PH-12100021

Parties involved

Contracting body: Centro Hospitalar de Lisboa Ocidental, EPE (CHLO)
Awardee: FRESENIUS KABI PHARMA PORTUGAL, LDA
Place of performance: Portugal, Lisboa, Lisboa; Portugal
NUTS region: Not stated

WHO BID

Awardee and competitors

Companies that IMPIC lists as the awardee and as competitors in this procedure.

Awardee: FRESENIUS KABI PHARMA PORTUGAL, LDA · Tax ID 504293753
Bidder: MYLAN, LDA. · Tax ID 502248793
Bidder: AMGEN BIOFARMACÊUTICA, LDA. · Tax ID 502942959
Bidder: SANDOZ FARMACÊUTICA, LDA. · Tax ID 506985261
Bidder: BIOGEN IDEC PORTUGAL · Tax ID 506415740

Values and timeline

Contract price: €23,280.00
Procedure base price: €26,952.00
Total effective price: Not reported on Portal BASE
Publication date: 8 November 2021
Award date: 18 August 2021
Signing date: 11 October 2021
Performance period: 180 days

The contract price is the value agreed in the contract, not the amount paid.

Procedure and framework

Contract type: Aquisição de bens móveis
Procedure type: Prior consultation (Consulta Prévia)
Award criterion: Monofator
CPV code: 33600000-6 - Produtos farmacêuticos
Legal basis: Artigo 20.º, n.º 1, alínea c) do Código dos Contratos Públicos
Regime: Código dos Contratos Públicos (DL111-B/2017) e Lei n.º 30/2021, de 21.05
Framework agreement: Not stated
Centralised procedure: No
Environmental criterion: No
Notice: Not stated
Procedure identifier: 5436759

Compare with other contracts

Search the same body, supplier, place or type of service to understand the context of the published index.

← Back to contracts